Morgan Stanley’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25K | Sell |
|
|||||
|
2025
Q1 | $1.76K | Hold |
|
|||||
|
2024
Q4 | $2.38K | Hold |
|
|||||
|
2024
Q3 | $5.58K | Sell |
|
|||||
|
2024
Q2 | $33.1K | Sell |
|
|||||
|
2024
Q1 | $93.7K | Sell |
|
|||||
|
2023
Q4 | $483K | Buy |
|
|||||
|
2023
Q3 | $114K | Sell |
|
|||||
|
2023
Q2 | $282K | Buy |
|
|||||
|
2023
Q1 | $20.9K | Sell |
|
|||||
|
2022
Q4 | $341K | Sell |
|
|||||
|
2022
Q3 | $305K | Sell |
|
|||||
|
2022
Q2 | $806K | Buy |
|
|||||
|
2022
Q1 | $152K | Sell |
|
|||||
|
2021
Q4 | $412K | Sell |
|
|||||
|
2021
Q3 | $518K | Buy |
|
|||||
|
2021
Q2 | $880K | Buy |
|
|||||
|
2021
Q1 | $14K | Sell |
|
|||||
|
2020
Q4 | $2.35M | Buy |
|
|||||
|
2020
Q3 | $1.83M | Buy |
|
|||||
|
2020
Q2 | $5K | Buy |
|
|||||
|
2020
Q1 | $2K | Buy |
|
|||||
|
2019
Q4 | $4K | Buy |
|
|||||
|
2019
Q3 | $3K | Sell |
|
|||||
|
2019
Q2 | $19K | Buy |
|
|||||
|
2019
Q1 | $2K | Sell |
|
|||||
|
2018
Q4 | $6K | Buy |
|
|||||
|
2018
Q3 | $8K | Buy |
|
|||||
|
2018
Q2 | $4K | Sell |
|
|||||
|
2018
Q1 | $7K | Sell |
|
|||||
|
2017
Q4 | $10K | Buy |
|
|||||
|
2017
Q3 | $11K | Sell |
|
|||||
|
2017
Q2 | $12K | Buy |
|
|||||
|
2017
Q1 | $16K | Buy |
|
|||||
|
2016
Q4 | $8K | Sell |
|
|||||
|
2016
Q3 | $13K | Buy |
|
|||||
|
2016
Q2 | $2K | Buy |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $1K | Sell |
|
|||||
|
2015
Q3 | $4K | Sell |
|
|||||
|
2015
Q2 | $44K | Buy |
|
|||||
|
2015
Q1 | $31K | Buy |
|
|||||
|
2014
Q4 | $33K | Sell |
|
|||||
|
2014
Q3 | $34K | Sell |
|
|||||
|
2014
Q2 | $45K | Buy |
|
|||||
|
2014
Q1 | $37K | Buy |
|